PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 13, 2026Brain Research0 citationsOpen Access

Exploring the role of glial cells and inflammatory cytokines in chronic muscle pain from rodent models

View Full Paper
MFM. C. C. A. FreitasMRMariana P. RibeiroMGMatias Cardoso Grande

Key Points

  • This research investigates the role of glial cells and inflammatory cytokines in chronic muscle pain due to gastrocnemius injury in rodent models.
  • Used a gastrocnemius injury model to induce chronic myositis in rodents.
  • Assessed nociceptive thresholds and locomotor activity to gauge pain and mobility.
  • Performed histological analysis of muscle tissue to evaluate inflammation and glial cell activity.
  • Administered pharmacological inhibition of microglia with minocycline to observe changes in pain response.
  • Analyzed serum cytokine levels to determine inflammatory profiles and compensatory mechanisms.
  • Myositis animals exhibited decreased nociceptive thresholds and impaired locomotion, indicating pain development.
  • Increased microglial activation was found in the lumbar spinal cord of myositis rodents.
  • Minocycline treatment improved nociceptive thresholds, showing glial modulation's potential for pain management.
  • Cytokine profile analysis revealed elevated IL-4 and IL-10, with reduced TNF-α and fractalkine levels, indicating compensatory anti-inflammatory responses.

Abstract

• Gastrocnemius injury model effectively mimics chronic muscle pain and inflammation. • Myositis animals exhibited reduced nociceptive thresholds and impaired locomotor activity. • Increased microglial activation in the lumbar spinal cord was associated with pain development. • Pharmacological inhibition of microglia improved nociceptive outcomes. • Cytokine profile revealed enhanced IL-4/IL-10 and reduced TNF-α and fractalkine, suggesting compensatory regulation. Musculoskeletal disorders are among the leading causes of disability worldwide, yet their underlying mechanisms remain incompletely understood. Experimental models of gastrocnemius muscle injury have been widely used to investigate the pathophysiology of chronic muscle pain. This study aimed to evaluate histological alterations in muscle tissue, nociceptive sensitivity, locomotor activity, and the role of spinal glial cells and inflammatory mediators following the induction of chronic myositis. Histological analyses revealed marked inflammation in the muscle tissue of myositis animals. Behavioral testing confirmed pain development, with reduced nociceptive thresholds compared to controls, as well as impaired locomotor activity. Increased expression of microglia in the lumbar spinal cord was also observed in myositis animals. Importantly, pharmacological inhibition of microglial activity using minocycline significantly improved nociceptive outcomes, reinforcing the potential of glial modulation in pain control. At the systemic level, cytokine analysis showed elevated levels of the anti-inflammatory cytokines IL-4 and IL-10, accompanied by reduced fractalkine and TNF-α levels in serum, suggesting activation of compensatory mechanisms that counterbalance the inflammatory process. Collectively, these findings advance our understanding of the cellular and molecular pathways involved in chronic muscle pain. By highlighting the contribution of glial cells and specific cytokines, our results support novel therapeutic approaches aimed at modulating neuroimmune interactions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Freitas et al. (2026) studied this question.

synapsesocial.com/papers/69b3ac9002a1e69014cce6cbhttps://doi.org/10.1016/j.brainres.2026.150260
Ask AI
Helpful
Bookmark
Share
View Full Paper